ERBB2 and neoplasm: Moreover, a longer retention time of HER–PEG–NDs was observed in the HER2-overexpressing tumor model than in the negative tumor model (4T1.2), suggesting that HER2 targetability has a great potential for sensitivity in the in vivo detection of tumors.